Relations (1)
cross_type 0.10 — supporting 1 fact
Ketamine is recognized as a prescriptible treatment for treatment-resistant depression in Israel, as established by the clinical evidence cited in [1].
Facts (1)
Sources
Effects of psychedelics on neurogenesis and broader neuroplasticity link.springer.com 1 fact
claimKetamine is a prescriptible treatment for treatment-resistant depression (TRD) in the USA and Israel, with many other countries implementing this treatment, according to Mathai et al. (2020).